Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer

Pancreatic cancer is one of the most lethal malignancies and is refractory to the available treatments. Pancreatic ductal adenocarcinoma (PDAC) expresses high level of inducible nitric oxide synthase (NOS2), which causes sustained production of nitric oxide (NO). We tested the hypothesis that an abe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Wang, Jian, He, Peijun, Gaida, Matthias, Yang, Shouhui, Schetter, Aaron J., Gaedcke, Jochen, Ghadimi, B. Michael, Ried, Thomas, Yfantis, Harris, Lee, Dong, Weiss, Jonathan M., Stauffer, Jimmy, Hanna, Nader, Alexander, H. Richard, Hussain, S. Perwez
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5288163/
https://ncbi.nlm.nih.gov/pubmed/27367029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10323
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados